2021 MedCan Speaker

Carmen Doran

Chief Executive Officer,
Helius Therapeutics

Helius Therapeutics is vertically-integrated and has a bold vision, to become a world leader in the research, development and marketing of next-generation medical cannabis products. 

Carmen Doran, CEO, has a strong international background in pharmaceutical operations including site and global roles in both human and animal health. Carmen holds a Masters’ Degree in Biomedical Engineering from the University of Canterbury.


All Sessions by Carmen Doran

Day 1 - Industry Summit

Time Industry Stream Science Stream
09:50
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis

More Speakers

Kai Keli’iho’omalu

Cultivation Manager

Dr Rachel Galettis

Clinical Trial Manager

Mitch Cuevas

Pharmaceutical Director

Peter Crock

Chief Executive Officer